SAVE THE DATE – Roma, 18-19 giugno 2021 Share Post navigation Dapagliflozin and the incidence of type 2 diabetes in patients with heart failure and reduced ejection fraction: an exploratory analysis from DAPA HFAssociation between diabetes and haematological malignancies: a population-based study
